|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Securities Owned Not Readily Marketable | ||||||||||||||||||||
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, less allowance for doubtful accounts of $10.7 in 2020 and $12.3 in 2019 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Finished products | ||||||||||||||||||||
| Products in process | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| VAT receivable | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Guaranteed notes receivable | ||||||||||||||||||||
| Investments in repurchase agreements | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right–of–use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Long-term future income tax benefits | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Investments in unconsolidated joint ventures | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Loans payable to banks | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Current portion of warranties | ||||||||||||||||||||
| VAT payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Promotion and customer incentives | ||||||||||||||||||||
| Accrued income tax | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Other Liabilities, Current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Pension and post-retirement benefits | ||||||||||||||||||||
| Unrecognized tax benefits classified as long term liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Long-term income tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock, 4,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock, $.01 par value, 400,000,000 shares authorized; shares issued: 79,237,625 in 2020; 79,147,135 in 2019; and shares outstanding: 51,374,175 in 2020; 51,267,324 in 2019 | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Treasury stock, at cost: 27,863,450 shares in 2020; 27,879,811 shares in 2019 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Foreign currency translation adjustments | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY | ||||||||||||||||||||
Loading...
